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Abstract:  Clinicians use general practice guidelines as a source of support for their intervention, but how much   
confidence should they place on these recommendations? How much confidence should patients place on these   
recommendations? Various instruments are available to assess the quality of evidence of research, such as the revised 
Wong scale (R-Wong) which examines the quality of research design, methodology and data analysis, and the revision of 
the assessment of multiple systematic reviews (R-AMSTAR), which examines the quality of systematic reviews.  
The Grading of Recommendation Assessment, Development, and Evaluation (GRADE) Working Group developed an  
instrument called the GRADE system in order to grade the quality of the evidence in studies and to evaluate the strength 
of recommendation of the intervention that is proposed in the published article. The GRADE looks at four factors to  
determine the quality of the evidence: study design, study quality, consistency, and directness. After combining the four 
components and assessing the grade of the evidence, the strength of recommendation of the intervention is established. 
The GRADE, however, only makes a qualitative assessment of the evidence and does not generate quantifiable data. 
In this study, we have quantified both the grading of the quality of evidence and also the strength of recommendation of 
the original GRADE, hence expanding the GRADE. This expansion of the GRADE (Ex-GRADE) permits the creation of 
a new instrument that can produce tangible data and possibly bridge the gap between evidence-based research and   
evidence-based clinical practice. 
Keywords: GRADE, AMSTAR, Revised AMSTAR, Wong scale, Systematic Review, Vaccination and Autism, Vaccination, 
Whitening, Bleaching, In-office Whitening, In-office Beaching, CPAP versus Oral Appliance, CPA, Sleep Apnea, Hypoxia, 
Evidence-Based Decision Making, Strength of Clinical Relevance, Quality of Evidence, Strength of Recommendation, Clinical 
Significance, Evidence-Based Clinical Practice, Evidence-Based Dentistry, Evidence-Based Medicine. 
INTRODUCTION 
Progress and advancement in science through research is 
continually reported in scientific journals. For a scientific 
journal to publish an article, the article goes through multiple 
peer reviews and edits, where the final, published version is 
viewed to be of the highest merit for many. For the most 
part, researchers, clinicians, and individuals who read scien-
tific articles may assume that the clinical trial, systematic 
review, observational study, etc. are conducted without flaw 
and that their data and results are correctly analyzed. For 
example, they may trust that the clinical trials are conducted  
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with blinds and placebos to ensure any possible means of 
preventing bias, that the Chi-Square test is used to test the 
homogeneity of the sampling distribution by evaluating a 
single variable and not multiple variables, and that the stud-
ies’ t-test is used to assess the statistically significant differ-
ence between two populations of interest and not three popu-
lations. As a result, many individuals, especially readers with 
limited background knowledge, tend to accept the findings 
and recommendations of scientific papers without question. 
Several instruments have been developed to assess the 
quality of the evidence of scientific papers such as the re-
vised Wong scale (R-Wong) [1] and the revised scale for the 
“assessment of multiple systematic reviews” (R-AMSTAR) 
[2]. The R-Wong
 examines the quality of research design, 
methodology and data analysis [1]. The “assessment of mul-
tiple systematic reviews” (AMSTAR) revised by Kung et al. 
(2010) as the R-AMSTAR is designed to assess the quality 
of the methodology of systematic reviews [2]. A systematic 32    The Open Dentistry Journal, 2012, Volume 6  Phi et al. 
review is defined as “the product of the process of systemati-
cally reviewing the research literature pertinent to the re-
search question” by addressing the PICO question [1-3]. The 
acronym PICO was developed to denote the evidence-based 
research question, consisting of: 
•  the problem patient population (P),  
•  the interventions (I) under  
•  the consideration or comparison (C), 
•  the clinical outcome of interest (O).  
The revised Wong scale (R-Wong), which is comprised 
of nine questions and evaluates the methodology and quality 
of primary sources. Each question is scored 1, 2, or 3 (1 = 
inappropriate, 2 = mediocre, 3 = appropriate), with a total 
scale ranging from 9-27 [1]. 
The “Grading of Recommendations Assessment, Devel-
opment, and Evaluation (GRADE)” instrument is a tool de-
veloped by the GRADE Working Group, which assesses 
both the quality of the evidence as well as the strength of 
recommendation [4]. The GRADE Working Group defines 
the quality of the evidence as “the extent to which one can be 
confident that an estimate of effect is correct” and defines 
the strength of a recommendation as “the extent to which one 
can be confident that adherence to the recommendation will 
do more good than harm
4.” Four components are also evalu-
ated when looking at a body of literature: 
•  study design, 
•  study quality, 
•  consistency, and directness.  
Study design refers to the type of design used in the re-
search, e.g. randomized trials and observational studies. 
Meanwhile, study quality refers to the methodology and exe-
cution of the study, e.g. whether a randomized trial is 
blinded or double-blinded. Consistency looks at the esti-
mates of effects among the studies and the consistencies 
and/or inconsistencies of the results, and directness refers to 
the extent in which the study conditions (e.g. study popula-
tion, the intervention, and outcomes) reflect the conditions of 
the population of interest [3]. 
The quality of evidence using the GRADE instrument is 
ultimately graded by the following scale: high, moderate, 
low, and very low. The overall quality of evidence, however, 
takes into consideration all four components of quality of 
evidence in the paper, and assigns these grades accordingly 
[4]. The strength of recommendation of a body of literature 
using the GRADE instrument follows this assignment: net 
benefits, trade-offs, uncertain trade-off, and no net benefits 
[4]. The GRADE is an instrument that aims to address the 
cost versus benefit concern that many patients and clinicians 
have prior to an intervention, and it is one of the various de-
cision aids (e.g. workbooks, computer-based resources, and 
visuals) that help guide individuals through the decision-
making process [5]. 
Although the GRADE draws a bridge between evidence-
based health practices and clinical practices, the criteria for 
establishing the quality of evidence and strength of recom-
mendation is qualitative and leaves tremendous room for 
bias. The GRADE instrument is not standardized in how a 
clinician or a patient would evaluate a body of literature for 
these two outcomes, since the majority of the judgment 
would inevitably be based on the individual’s beliefs and 
opinions. As a result, we have expanded the GRADE to pro-
vide systematic and unbiased grading procedure in assessing 
the quality of the evidence and the strength of recommenda-
tion. The Ex-GRADE does not alter the purpose and signifi-
cance of the original GRADE instrument. Rather, it provides 
criteria for the clinician and the patient to systematically 
evaluate these two components (See Appendix 1 for the 
grading criteria). Whether they are looking at primary or 
secondary sources (e.g. clinical trials and systematic re-
views), patients and clinicians can gain insight into how well 
a research study was conducted. They are also able to gauge 
how substantial and reliable their data/data analysis is. By 
incorporating the R-Wong and the R-AMSTAR into the Ex-
GRADE, this instrument is able to assess the quality of evi-
dence and the strength of the clinical recommendation in a 
quantitative manner, enabling the critical analyses of the 
data, which in turn help to identify the qualitative signifi-
cance of the research at hand [6, 7]. With this literature, we 
provide the validation of the “strength of recommendation” 
segment of Ex-GRADE with respect to evidence-based 
clinical decision making. By incorporating the R-Wong and 
the R-AMSTAR, in which both have been previously vali-
dated [1, 2] into the Ex-GRADE as the quantitative instru-
ments in assessing the quality of evidence, no additional 
validation for the first component of the Ex-GRADE is nec-
essary in validating this instrument as a whole. 
METHOD 
The Ex-GRADE was independently validated in three 
distinct and unrelated fields of health care: in-office teeth 
whitening, sleep apnea, and vaccination. The study regarding 
in-office teeth whitening aimed to assess the strength of rec-
ommendation for clinical trials in aesthetic care. The topic of 
sleep apnea also evaluated the strength of recommendation 
in the field of curative medicine, and systematic reviews 
were evaluated rather than clinical trials. For vaccinations, 
we assessed the strength of clinical recommendation of sys-
tematic reviews in preventive care.  
The PICO question in each topic formed the basis for the 
inclusion and exclusion criteria in the literature search with 
various electronic databases (The National Library of Medi-
cine (Pubmed), MEDLINE, the Cochrane Library, Google 
Scholar, the American Dental Association (ADA) research 
database, Embase, Ovid SP, Bandolier, and Web of Science). 
Manual search was used for additional articles not digitally 
posted. Gray literature and any articles that were not written 
in English were excluded. The remaining inclusion and ex-
clusion criteria of the literature search were specific for the 
individual PICO question for each topic chosen. 
Nine independent readers (three readers for the study of 
in-office teeth whitening, three readers for the study of sleep 
apnea, and three readers for the study of vaccination) were 
trained and standardized in order to eliminate any inconsis-
tencies among the readers and to prevent any misinterpreta-
tions of the Ex-GRADE criteria. A preliminary trial of the Expanding the Grading of Recommendations Assessment  The Open Dentistry Journal, 2012, Volume 6    33 
Ex-GRADE scoring was performed to ensure that each of 
the nine readers read the literature critically and consistently. 
The trial was run with the R-Wong for the body of literature 
composed of primary sources, and with the R-AMSTAR for 
the body of literature composed of systematic reviews. An-
other test trial was conducted for the “Strength of Recom-
mendation” portion of the Ex-GRADE for all papers, with-
out discriminating between primary sources and systematic 
reviews. Any discrepancies in the scores were discussed un-
til a consensus was attained for the manner in which they 
followed the Ex-GRADE scoring criteria. After all nine 
readers had been trained and their judgments were standard-
ized, the reading and scoring of the articles were done inde-
pendently among all of the readers. All readers were blind 
from one another’s scoring. An additional member of the 
research team compiled the data, averaged the scores (to 
obtain the means of scores), and analyzed the scores of the 
readers so the analyses and interpretations of the data are 
unbiased. 
We used the Friedman test for non-parametric analysis of 
factorial designs using the Medical Data Analysis System 
(MDAS) software (EsKay Software, Pittsburg, 2004). Be-
cause the R-Wong and the R-AMSTAR are instruments that 
have already been validated, the analyses for scores received 
using the R-Wong or the R-AMSTAR were conducted ac-
cording to the original methodology dictated by the creators. 
When evaluating primary sources that consisted of clinical 
trials, the scores were spanned across nine columns (corre-
sponding to the nine questions of the R-Wong). However, if 
the primary sources did not contain clinical trials, the scores 
were inputted into the table using eight columns, as one 
question of the R-Wong only pertained to clinical trials [1]. 
When assessing the quality of evidence for systematic re-
views using the R-AMSTAR, the scores were inserted across 
eleven columns to correspond to the test’s eleven domains 
[2]. For the “Strength of Recommendation” section, the 
means of scores among the three readers were inputted 
across eight columns in the table, each column correspond-
ing to one of the eight questions of the Ex-GRADE. An al-
pha level () of 0.05 was used as the level of statistical sig-
nificance. A high mean of scores and a low variance signi-
fied strength in that particular domain of clinical recommen-
dation. 
RESULTS 
The R-Wong and R-AMSTAR have been previously 
validated [1, 2]. Therefore, the focus of this study was in 
validating the “strength of recommendation” portion of the 
Ex-GRADE, the second segment of the Ex-GRADE. It is 
important to keep in mind that the “strength of recommenda-
tion” assessment portion cannot be used in isolation. By 
looking at Fig. (1), note that either the R-Wong or the R-
AMSTAR are used prior to assessing the strength of clinical 
recommendation, depending on the type of studies that are 
compiled (the R-Wong would be used for primary sources, 
and the R-AMSTAR would be used for systematic reviews). 
In-Office Teeth Whitening 
In our literature search to assess the strength of clinical 
recommendation regarding the use or disuse of light in in-
office teeth whitening, we found 315 articles that fit our in-
clusion and exclusion criteria based on the PICO question. 
After filtering for articles that compared in-office bleaching 
with light and in-office bleaching without light, we had a 
total of 16 articles [8-23] in which we used in the validation 
of the Ex-GRADE. 
The average scores for the in-office teeth whitening lit-
erature are shown in Table 1. Because three readers inde-
pendently scored these articles, the inter-rater reliability was 
calculated between Reader 1 and Reader 2, between Reader 
2 and Reader 3, and between Reader 1 and Reader 3. The 
inter-rater reliability (Pearson correlation coefficient, r) 
among the readers were 0.86, 0.92, and 0.91, respectively. 
The mean inter-rater reliability is 0.89, with a shared vari-
ance of 80% (r
2=0.80), indicating that the scores were indeed 
correlated.  
As shown in Table 1, all of the Ex-GRADE scores given 
to the clinical trials regarding in-office bleaching fell within 
the 95% confidence interval of the sample (mean ± standard 
deviation: 20.88 ± 1.05; 95% confidence interval (CI95: 
19.82-21.93) except for two papers. The two papers that did 
Table 1. Average Ex-GRADE Scores Across Three Independent Readers - In-Office Teeth Whitening Literature
Paper 1 2 3 4 5 6 7 8 Total
1 2.00 3.00 2.00 2.00 4.00 3.00 2.00 3.00 21.00
2 1.33 2.67 2.33 2.00 3.67 3.00 2.33 3.00 20.33
3 1.00 2.33 2.00 2.00 4.00 3.33 3.00 3.00 20.67
4 2.00 3.00 2.00 2.00 4.00 4.00 3.00 3.00 23.00
5 2.00 3.00 2.00 2.00 3.33 2.33 2.00 3.00 19.67
6 2.00 1.00 1.33 2.00 3.67 4.00 4.00 3.67 21.67
7 1.67 2.00 2.00 2.00 4.00 4.00 2.00 3.00 20.67
8 3.00 1.67 2.00 2.00 4.00 3.00 2.33 2.00 20.00
Mean 1.88 2.33 1.96 2.00 3.83 3.33 2.58 2.96 20.88
St. Dev 0.59 0.73 0.28 0.00 0.25 0.62 0.71 0.45 1.05
(Friedman non-parametric ANOVA equivalent, p < 0.0001)34    The Open Dentistry Journal, 2012, Volume 6  Phi et al. 
not fall within this interval were Paper 4 (total score = 23.00) 
and Paper 5 (total score = 19.67). Based on the scoring crite-
ria presented in Fig. (1), all eight papers scored within the 
16- 23 point range for “good with some uncertainty.” As a 
translation, the scores show that for all of these papers, the 
intervention proposed within these bodies of literature is 
recommended for both the clinician, who executes the inter-
vention (i.e., clinical relevance), and for the patient (i.e., in-
creased patient satisfaction, increased health literacy, in-
creased empowerment to be active participant in the treat-
ment decision-making process). 
With p < 0.0001, a significant difference is present in the 
scores among the eight domains of clinical recommendation. 
Table 1 shows that question 1 (the quality of evidence) and 
question 3 (alternative recommendation) have low mean 
values (1.88 ± 0.59 and 1.96 ± 0.28, respectively), indicating 
that these two domains are relatively weak among these pa-
pers. With a mean score of 2.00 ± 0.00, the strength of the 
domain in question 4 (availability of resources) is relatively 
weak, yet uniform, among this body of literature. The overall 
scores in these three domains (represented by questions 1, 3 
and 4) are lower compared to the other domains (represented 
by questions 2, 5, 6, 7, and 8), resulting in a significant dif-
ference overall among the eight domains. 
Sleep Apnea 
Due to the limitations of the available, published litera-
ture, no systematic reviews were found that compared pa-
tients’ compliance using continuous positive airway pressure 
(CPAP) versus oral appliances. As a result, we were re-
stricted to systematic reviews that evaluated the use of CPAP 
(independent of oral appliances) and systematic reviews that 
evaluated the use of oral appliances (independent of CPAP). 
We had the option of using primary resources for this re-
search topic, but systematic reviews as seen in Fig. (2) have 
a much higher level of evidence compared to primary 
sources (e.g. clinical trials) [24]. In our search for systematic 
reviews regarding sleep apnea, we initially found 16 system-
atic reviews for CPAP compliance and 4 systematic reviews 
for oral appliance compliance. After formulating our PICO 
question comparing whether CPAP or oral appliance treat-
ment had a higher patient compliance, we excluded 10 CPAP 
compliance articles and 3 oral appliance compliance articles 
that either did not pertain to our research question or were 
not indeed systematic reviews, resulting in a total of 6 sys-
tematic reviews for analysis of CPAP compliance [25-30] 
and 1 for oral appliance compliance [31]. Table 2 and Table 
3 show the average scores among the second set of three 
readers for the sleep apnea literature. For the scoring, two 
independent readers scored the 6 systematic reviews regard-
ing CPAP use, and two independent readers scored the 1 
systematic review regarding oral appliance use. The inter-
rater reliability between Reader 4 and Reader 5 is 0.95 (r
2 = 
0.90), and the inter-rater reliability between Reader 4 and 
Reader 6 is 0.96 (93% shared variance). 
The analyses of articles were conducted in the same 
manner in which the analyses of the in-office whitening lit-
erature were conducted. Half of the articles for the CPAP 
compliance literature (paper 1, 2, and 5) fell within the 95% 
confidence interval of the average total means of the six pa-
pers as a whole (24.33 ± 2.96). The remaining three papers 
(paper 3, 4 and 6) received scores that fell outside of this 
confidence interval (total score of 28, 28, and 21, respec-
tively). Using the Ex-GRADE scoring guideline as presented 
 
Fig. (1). Ex-GRADE. 
Table 2. Average Scores Across Two Independent Readers – CPAP Compliance Literature 
Papers 1 2 3 4 5 6 7 8 Total
1 1.00 4.00 2.50 2.00 3.00 2.00 4.00 4.00 22.50
2 3.50 2.50 3.00 2.00 3.50 3.00 3.00 3.00 23.50
3 4.00 3.00 3.00 3.00 3.00 4.00 4.00 4.00 28.00
4 4.00 3.00 3.00 2.00 4.00 4.00 4.00 4.00 28.00
5 1.00 3.00 4.00 2.00 3.00 2.00 4.00 4.00 23.00
6 1.00 3.00 3.00 2.00 3.00 2.00 4.00 3.00 21.00
Mean 2.42 3.08 3.08 2.17 3.25 2.83 3.83 3.67 24.33
St. Dev 1.56 0.49 0.49 0.41 0.42 0.98 0.41 0.52 2.96
(Friedman non-parametric ANOVA equivalent, p = 0.1558) Expanding the Grading of Recommendations Assessment  The Open Dentistry Journal, 2012, Volume 6    35 
in Fig. (1), papers 1, 5, and 6 were given strengths of rec-
ommendation that were “good with some uncertainty,” 
whereas papers 2, 3, and 4 received “strong” strengths of 
recommendation. Table 3 shows the average scores given to 
the article that focused on oral appliance compliance, having 
a total mean of 23.50 (mean score across questions = 2.94; 
standard deviation = 1.15). By receiving a total average 
score of 23.50 (which rounds to 24), this intervention given 
in this article qualifies as a “strong” recommendation for 
both the clinician and the patient. Because only one system-
atic review was found regarding patients’ compliance using 
oral appliances, it is difficult to formulate a general conclu-
sion of the eight domains due to the low number of available 
literature. 
The Friedman non-parametric p-value for both bodies of 
literature did not show a statistical significance across the 
eight domains of the Ex-GRADE (CPAP: p = 0.1558; oral 
appliance: p = 0.5014). In the CPAP compliance literature, 
question 7 (clinical significance) and 8 (patient compliance) 
received the highest mean scores using the Ex-GRADE crite-
ria (question 7: 3.83 ± 0.41; question 8: 3.67 ± 0.52), indicat-
ing that these domains were strong throughout the six papers. 
For the systematic review related to oral appliance, question 
4 (availability of resources), 7 (clinical significance), and 8 
(patient compliance) received a score of 4, indicating that 
these domains were well represented and addressed in this 
paper. 
Vaccination 
 Our initial search for systematic reviews that investi-
gated whether vaccinations led to the development of autism 
yielded 15 articles. Among the 15 articles, 11 of the articles 
were excluded because the articles were either reviews in-
stead of systematic reviews, or because they did not assess 
the direct correlation of vaccination and autism. As a result, 
4 articles [32-35] were used in our validation of the “strength 
of recommendation” section of the Ex-GRADE. 
Table 4 contains the average scores given for the vacci-
nation literature, with an inter-rater reliability of 0.91 be-
tween Reader 7 and Reader 8, an inter-rater reliability of 
0.94 between Reader 8 and Reader 9, and an inter-rater reli-
ability of 0.92 between Reader 7 and Reader 9. The average 
inter-rater reliability among the three readers is 0.92 (85% 
shared variance). 
With an Ex-GRADE score of 21.33 (paper 1) and an Ex-
GRADE score of 20.67 (paper 2), these two papers fell 
within the 95% confidence interval (21.08 ± 1.26). However, 
paper 3 received a score of 22.67 and paper 4 received a 
score of 19.67, lying outside of this confidence interval. Us-
ing the scoring rubric for the Ex-GRADE, all four papers 
qualify to have strengths of recommendation that are “good 
with some uncertainty.” This indicates that the interventions 
suggested in these articles are recommended for both the 
clinician and the patient. However, more research must be 
conducted in order to have a strong recommendation for 
these interventions. 
A Friedman non-parametric p-value of 0.0027 signifies 
that there is statistical significance among the eight domains 
 
Fig. (2). Levels of quality of evidence pyramid. 
Table 3. Average Scores Across Two Independent Readers – Oral Appliance Compliance Literature 
Papers  1  2  3  4  5  6  7  8  Total  Mean  St. Dev 
1  1.50  3.00  3.00  1.00  4.00  3.00  4.00  4.00  23.50  2.94  1.15 
(Friedman non-parametric ANOVA equivalent, p = 0.5014) 
Table 4. Average Ex-GRADE Scores Across Three Independent Readers – Vaccination Literature
Papers 1 2 3 4 5 6 7 8 Total
1 1.00 3.00 3.00 1.67 3.00 3.00 2.67 4.00 21.33
2 1.00 3.00 2.67 2.00 3.00 2.00 3.00 4.00 20.67
3 1.00 3.00 3.00 2.00 3.67 3.00 3.00 4.00 22.67
4 1.00 2.00 3.00 2.00 3.33 2.00 3.00 3.33 19.67
Mean 1.00 2.75 2.92 1.92 3.25 2.50 2.92 3.83 21.08
St. Dev 0.00 0.50 0.17 0.17 0.32 0.58 0.17 0.33 1.26
(Friedman non-parametric ANOVA equivalent, p = 0.0027)36    The Open Dentistry Journal, 2012, Volume 6  Phi et al. 
of the Ex-GRADE with respect to these four systematic re-
views. In a situation where the score for the Ex-GRADE is 
weak for various papers, those papers would be disregarded 
from the final analysis overall recommendation for the inter-
vention. By disregarding low-scoring papers, we would be 
able to concentrate on the results from the high-quality pa-
pers, which essentially lead to a stronger recommendation. 
The score for Question 1 (the quality of evidence) is ex-
tremely low, with a mean of 1.00 ± 0.00, suggesting that the 
quality of the evidence among all of these four papers is 
weak. The quality of evidence refers to the scores received 
using either the R-Wong
 [1] or the R-AMSTAR [2], so in 
this body of literature, a quality of the systematic reviews is 
weak. The mean of the scores for question 4 (availability of 
resources) is also low (1.92 ± 0.17) among these papers, re-
sulting in a significant difference from the other domains 
which received higher scores overall (represented by ques-
tions 2, 3, 5, 6, 7, and 8). 
DISCUSSION 
With these collected data as provided in Tables 1-4, the 
Ex-GRADE does provide sufficient quantification in evalu-
ating the quality of the evidence and the strength of the clini-
cal recommendation. Not only does the Ex-GRADE give 
insight into the efficacy of the proposed intervention through 
the incorporation of the R-Wong [1] (which evaluates the 
quality of evidence of primary sources) and the R-AMSTAR 
[2]
  (which evaluates the quality of evidence of systematic 
reviews), it also addresses the effectiveness of the interven-
tion through the “strength of recommendation” section of the 
Ex-GRADE (Appendix 1). The scoring intervals that signi-
fies whether a body of literature is “weak” in terms of clini-
cal recommendation, “good with some uncertainty” in the 
clinical recommendation, or “strong” clinical recommenda-
tion is equally divided among these three recommendations, 
where a paper receiving less than one-third of the possible 
points for the strength of recommendation portion (8-15 
points) would be designated as “weak,” a paper that receives 
a score that falls within the middle third (16 -23 points) 
would be considered “good with some uncertainty,” and a 
paper that receives a score in the upper third would have a 
“strong” strength of recommendation. This same point dis-
tribution can also apply when an average of the scores are 
taken from multiple readers. In the case where a score falls 
between two intervals (e.g., 23.2), the score is rounded to the 
nearest integer. 
The criteria for the strength of clinical recommendation 
were content-validated by several clinicians in the health 
care field, ensuring that these are the basis in which a rec-
ommendation is given for a particular intervention. In the 
clinical setting, the recommendation is not based solely on 
the efficacy of the intervention, but also takes into account 
the risk associated with the intervention, the total cost (in-
cluding monetary cost), the availability of resources, and 
patient compliance. The clinician has a responsibility to pro-
vide their patients with the best treatments [5] and should 
provide alternative recommendations for the intervention in 
the case that the proposed intervention is unattainable or 
undesirable for the patient and/or clinician. 
There is a terminology in the “strength of recommenda-
tion” portion of the Ex-GRADE that we want to define for 
clarity purposes. Question 7 asks if the results are “clinically 
significant.” Clinical significance is essentially determined 
by two determinants: the nature of the benefit (if the benefit 
is tangible or intangible), and whether this benefit is likely to 
be attainable. A tangible benefit can be realized in a person’s 
mind (e.g. a patient’s well-being or feeling). An intangible 
benefit is one that the individual’s mind does not consciously 
realize (e.g. changes in enamel mineralization level) [36]. 
The provided criteria that are given in Question 7 can be 
fulfilled by either types of benefits (tangible or intangible). 
The importance of this domain is to ensure that the interven-
tions that are recommended to the patients are essentially 
worthwhile. 
The Ex-GRADE expands the original GRADE to provide 
quantification of the quality of evidence and strength of   
recommendation of the body of literature, partaking in the 
final stages of evidence-based practice [37]. This quantifica-
tion allows us to critically assess the validity and reliability 
of the evidence that is provided in available literature - an 
essential component of evidence-based research [38]. As a 
result, the specific strengths and weaknesses of the study can 
be critically evaluated in a single study, and the results can 
also be compared to the strengths and weaknesses of other 
bodies of literature. The total score received by the primary 
source or systematic review helps the patient or clinician to 
gauge whether the intervention or recommendation proposed 
in the paper is viable, or whether the individual should look 
into other alternatives in the domain of curative, palliative, 
or preventive care. In essence, the Ex-GRADE is an instru-
ment that aims to bridge the gap between evidence-based 
research and evidence-based clinical practice [7], hopefully 
unifying these two branches and providing a means of   
communication between those providing insight from a   
research-based perspective and those physically providing 
the services for the intervention in the clinical setting. 
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APPENDIX 1 
The “Strength of Recommendation” section of the Ex-GRADE (Expansion of the Grading of Recommendation Assessment, 
Development, and Evaluation) is graded on a point-based system, with 1 being the lowest score possible per question and 4 
being the highest score possible per question. With a total of 8 questions, the minimum total score possible a primary source or 
systematic review will receive is 8 & the maximum total score possible is 32. 
1.  Are the findings and quality of evidence of the study applicable to the specific recommendation? (Score from 
“quality of evidence” section. E.g. A clinical trial that receives a score of 23 using the R-Wong scale would fulfill 2 
criteria: 1 criterion for scoring at least 19 & 1 criterion for scoring at least 22  hence will receive a score of 3 using 
the Ex-GRADE according to the grading scale below.) 
•  Fulfills 3 of the criteria  4 
•  Fulfills 2 of the criteria  3 
•  Fulfills 1 of the criteria  2 
•  Fulfills 0 of the criteria  1 
CRITERIA: 
For Primary Sources 
R-Wong score of at least 25 for clinical trials OR at least 22 for all other primary sources 
R-Wong score of at least 22 for clinical trials OR at least 20 for all other primary sources 
R-Wong score of at least 19 for clinical trials OR at least 17 for all other primary sources 
For Systematic Reviews: 
Systematic Reviews – R-AMSTAR score of at least 40 for systematic reviews 
Systematic Reviews – R-AMSTAR score of at least 36 for systematic reviews 
Systematic Reviews – R-AMSTAR score of at least 31 for systematic reviews 
2.  Are risk and affordability considered when given the recommendation for the intervention? 
•  Fulfills 3 of the criteria  4 
•  Fulfills 2 of the criteria  3 
•  Fulfills 1 of the criteria  2 
•  Fulfills 0 of the criteria  1 
CRITERIA: 
Recognition of risk for the intervention is directly stated, or acknowledgement of risk can be 
inferred 
Recognition of possible adverse effects post-intervention is directly stated, or acknowledgement of 
possible adverse effects post-intervention can be inferred 
Recognition of cost for the intervention is directly stated, or approximate and/or relative cost for the 
intervention can be inferred 
Recognition of affordability is directly stated or can be inferred 
3.  Are alternative recommendations given, if appropriate? 
•  Fulfills 3 of the criteria  4 
•  Fulfills 2 of the criteria  3 
•  Fulfills 1 of the criteria  2 
•  Fulfills 0 of the criteria  1 
CRITERIA: 
Alternative suggestions or recommendations were given with regards to risk during the intervention 38    The Open Dentistry Journal, 2012, Volume 6  Phi et al. 
Alternative suggestions or recommendations were given with regards to possible adverse effects 
following the intervention 
Alternative suggestions or recommendations were given with regards to cost & affordability 
Explicitly states that no alternative recommendations are appropriate with regards to risk during the 
intervention 
Explicitly states that no alternative recommendations are appropriate with regards to possible ad-
verse effects following the intervention 
Explicitly states that no alternative recommendations are appropriate with regards to cost & afforda-
bility 
4.  Is availability of resources for the population of interest taken into account prior to formulating the 
recommendation? [Is the recommendation practical for the population of interest?] 
•  Fulfills 3 of the criteria  4 
•  Fulfills 2 of the criteria  3 
•  Fulfills 1 of the criteria  2 
•  Fulfills 0 of the criteria  1 
CRITERIA: 
Insurance coverage is available for the recommended intervention at hand [Some research on vari-
ous insurance plans may need to be done] 
Other alternative funding aside from insurance is available for the recommended intervention at 
hand [Some research for alternative funding may need to be done] 
Resources in terms of equipment & supplies for the recommendation are easily accessible in clinical 
practice [This may require some prior knowledge of the equipments & supplies provided in the 
standard setting of the population of interest] 
5.  Is a measureable guideline provided to monitor the intended outcome(s) of the recommendation? [Was there 
a method provided that can measure the effectiveness of the recommendations? How did they/will they measure the 
outcomes or results?] 
•  Fulfills 3 of the criteria  4 
•  Fulfills 2 of the criteria  3 
•  Fulfills 1 of the criteria  2 
•  Fulfills 0 of the criteria  1 
CRITERIA: 
Method of monitoring the intended outcome of the recommendation is given 
Method of monitoring the intended outcome can produce tangible data for the researcher 
Method of analyzing the data produced from monitoring the intended outcome is provided 
6.  Are the results of the intervention statistically significant? 
•  Fulfills 3 of the criteria  4 
•  Fulfills 2 of the criteria  3 
•  Fulfills 1 of the criteria  2 
•  Fulfills 0 of the criteria  1 
CRITERIA: 
Chosen methodology of the research is appropriate for the intended recommendation at hand 
Methodology of the research (e.g. methodology of the clinical trial, methodology of the systematic 
review, etc.) is executed properly & accurately 
Statistical analysis of the data shows statistical significance with p < 0.05 Expanding the Grading of Recommendations Assessment  The Open Dentistry Journal, 2012, Volume 6    39 
7.  Are the results clinically significant? 
•  Fulfills 3 of the criteria  4 
•  Fulfills 2 of the criteria  3 
•  Fulfills 1 of the criteria  2 
•  Fulfills 0 of the criteria  1 
CRITERIA: 
For curative medicine/care, palliative medicine/care, or aesthetic/cosmetic care: 
The intervention alters the pathophysiology of the disease/issue in question 
The intervention can be realistically carried out & successfully executed in the clinical setting 
The time it takes for noticeable results to be seen post-intervention is reasonable taking into consid-
eration the total cost of the intervention (Cost = monetary expenses & risk, both during the interven-
tion & post-intervention) 
For preventive medicine/care: 
The intervention does not alter the pathophysiology of the disease/issue in question 
The intervention does not induce another pathology aside from the disease/issue in question 
The intervention can be realistically carried out & successfully executed in the clinical setting 
8.  Is the patient likely to comply with the suggested recommendation? 
•  Fulfills 3 of the criteria  4 
•  Fulfills 2 of the criteria  3 
•  Fulfills 1 of the criteria  2 
•  Fulfills 0 of the criteria  1 
CRITERIA: 
Minimal level of invasiveness to the patient 
Minimal level of side effects after the given intervention 
Benefits of the recommendation outweigh its total cost (Cost = monetary expenses & risk, both dur-
ing the intervention & post-intervention) 
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